Search
for
Sort by
Research 91–120 of 284
- Cell Density-Dependent Upregulation of PDCD4 in Keratinocytes and Its Implications for Epidermal Homeostasis and Repair
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- British Hair and Nail Society
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- IV Międzynarodowe Sympozjum Studenckich Kół Naukowych Środowisko – Roślina – Zwierzę – Produkt Streszczenia
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Hair relaxer use and breast cancer risk by tumor molecular subtypes.
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Breast cancer in a transgender man
- Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts
- Abstract P1-12-19: A case report of successful hair preservation using scalp cooling with doxorubicin and cyclophosphamide during pregnancy
- A Case Control Study to Determine the Correlation Between Serum Ferritin Levels and Chronic Telogen Effluvium in a Tertiary Hospital, Mandya
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Heavy metals in biological samples of cancer patients: a systematic literature review
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
- PROTACs: A novel strategy for cancer drug discovery and development
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Prophylaxis and Management of Skin Toxicities
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review